Michael Biermer

5PUBLICATIONS
16CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMolecular medicineRespiratory diseasesGene and molecular therapyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 05, 2025
Peginterferon alpha-2a add-on to siRNA JNJ-73763989 in untreated patients with HBeAg-positive chronic hepatitis B virus (HBV) infection: the phase 2 REEF-IT study.

Patrick T F Kennedy, Scott Fung, Maria Buti

|May 15, 2025
Population Pharmacokinetics of siRNA JNJ-73763989 in Healthy Participants and Patients With Chronic Hepatitis B.

Tetsuro Ogawa, Nele Goeyvaerts, Thomas N Kakuda

|Sep 12, 2024
Long-term hepatitis B surface antigen response after finite treatment of ARC-520 or JNJ-3989.

Lung Yi Mak, Christine I Wooddell, Oliver Lenz

|Feb 14, 2023
Pharmacokinetics of JNJ-73763989 and JNJ-56136379 (Bersacapavir) in Participants With Moderate Hepatic Impairment.

Thomas N Kakuda, Atef Halabi, Gernot Klein

|Jan 25, 2023
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection.

Harry L A Janssen, Jinlin Hou, Tarik Asselah

Pageof 1

Frequent Collaborators

3 joint publications

Thomas Naoki Kakuda

2 joint publications

Tarik Asselah

1 joint publications

Jinlin Hou

1 joint publications

Fabien Zoulim